CDC20 and breast carcinoma: Cell division cycle 20 homolog (CDC20) is also studied as one of the significant regulators of the cell cycle in multiple cancer types including breast cancer (Karra et al., 2014), prostate cancer (Zhang et al., 2019), and colorectal cancer (Wu et al., 2013).